Reputation As A Competitive Advantage In International Market Entry In The PharmaceuticalVargas-Hernández JG1* and Wong Dan AT2
- *Corresponding Author:
- Vargas-hernández JG
Universidad de Guadalajara Periférico
Norte 799 Edif. G201-7, Los Belenes
C.P. 45100, Zapopan, Jalisco México
Tel: +523337703340, Ext. 25685
E-mail: [email protected], [email protected], [email protected]
Received date: May 18, 2015; Accepted date: June 24, 2015; Published date: July 02, 2015
Citation: Vargas-Hernández JG, Wong Dan AT (2015) Reputation as a Competitive Advantage in International Market Entry in the Pharmaceutical. Int J Econ Manag Sci 4:260. doi:10.4172/2162-6359.1000260
Copyright: © 2015 Vargas-Hernández JG, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
The present research attempts to analyze from a theoretical and methodological view of the competitive advantage that companies have to use the reputation as a generating tool of market value and this is a difficult intangible factor to imitate that facilitates the company to entre international markets. The largest pharmaceutical companies in the world and Mexico will be studied, from its inception and its market value. Finally it is concluded that the pharmaceutical industry has been characterized as one the most difficult markets to enter for their high entry barriers and reputational capital.